Spots Global Cancer Trial Database for stage iv renal cell cancer
Every month we try and update this database with for stage iv renal cell cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer | NCT00004135 | Kidney Cancer Melanoma (Skin) | filgrastim therapeutic all... cyclophosphamid... fludarabine pho... peripheral bloo... | 18 Years - 65 Years | University of Chicago | |
| Sunitinib Malate in Treating Patients With Kidney Cancer | NCT00943839 | Kidney Cancer | sunitinib malat... laboratory biom... pharmacological... | 18 Years - | Centre Antoine Lacassagne | |
| Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab | NCT00866320 | Kidney Cancer | sorafenib tosyl... | 18 Years - | Case Comprehensive Cancer Center | |
| OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors | NCT00471432 | Bladder Cancer Breast Cancer Kidney Cancer Lung Cancer Ovarian Cancer Prostate Cancer Unspecified Adu... | custirsen sodiu... docetaxel pharmacological... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer | NCT00002846 | Kidney Cancer | aldesleukin conventional su... | 18 Years - | National Cancer Institute (NCI) | |
| Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer | NCT00176501 | Kidney Cancer | therapeutic all... | 18 Years - 75 Years | Rutgers, The State University of New Jersey | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer | NCT00005038 | Kidney Cancer | aldesleukin histamine dihyd... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery | NCT01061411 | Clear Cell Sarc... Recurrent Renal... Stage III Renal... Stage IV Renal ... | Dalteparin Pharmacological... Sunitinib Malat... | 18 Years - | Roswell Park Cancer Institute | |
| NGR-TNF in Treating Patients With Advanced Solid Tumors | NCT00098943 | Colorectal Canc... Head and Neck C... Kidney Cancer Unspecified Adu... | CNGRC peptide-T... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers | NCT01846520 | Healthy Subject Localized Trans... Metastatic Tran... Psychosocial Ef... Recurrent Bladd... Recurrent Cervi... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Recurrent Trans... Recurrent Ureth... Recurrent Uteri... Regional Transi... Stage II Bladde... Stage II Renal ... Stage II Urethr... Stage IIA Cervi... Stage IIA Colon... Stage IIA Gastr... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Pancr... Stage IIA Recta... Stage IIA Uteri... Stage IIB Cervi... Stage IIB Colon... Stage IIB Gastr... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Pancr... Stage IIB Recta... Stage IIB Uteri... Stage IIC Colon... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Recta... Stage III Bladd... Stage III Pancr... Stage III Renal... Stage III Ureth... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Gast... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Gast... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Uter... Stage IV Bladde... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Urethr... Stage IVA Cervi... Stage IVA Colon... Stage IVA Recta... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Colon... Stage IVB Recta... Stage IVB Uteri... Ureter Cancer Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIB Lung... | educational int... telephone-based... quality-of-life... questionnaire a... | 18 Years - | City of Hope Medical Center | |
| Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer | NCT00278174 | Kidney Cancer | recombinant int... | 18 Years - | Case Comprehensive Cancer Center | |
| Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer | NCT00176501 | Kidney Cancer | therapeutic all... | 18 Years - 75 Years | Rutgers, The State University of New Jersey | |
| Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer | NCT00899860 | Kidney Cancer | - 120 Years | Wake Forest University Health Sciences | ||
| Sunitinib Malate in Treating Patients With Kidney Cancer | NCT00943839 | Kidney Cancer | sunitinib malat... laboratory biom... pharmacological... | 18 Years - | Centre Antoine Lacassagne | |
| Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer | NCT00126503 | Chromophobe Ren... Clear Cell Rena... Papillary Renal... Recurrent Renal... Sarcomatoid Ren... Stage IV Renal ... | Bevacizumab Sorafenib Tosyl... Pharmacological... Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer | NCT00003553 | Kidney Cancer | HLA Matched Per... | 18 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
| Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer | NCT00020540 | Kidney Cancer Melanoma (Skin) | recombinant CD4... recombinant flt... | 16 Years - | National Cancer Institute (NCI) | |
| PS-341 in Treating Patients With Metastatic Kidney Cancer | NCT00017329 | Kidney Cancer | bortezomib | - | National Cancer Institute (NCI) | |
| Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer | NCT00541008 | Kidney Cancer | sunitinib malat... | 18 Years - 120 Years | UNICANCER | |
| Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer | NCT01684397 | Clear Cell Rena... Stage IV Renal ... | Bevacizumab Laboratory Biom... Pazopanib Hydro... Pharmacological... | 18 Years - | Roswell Park Cancer Institute | |
| Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT00112476 | Recurrent Melan... Recurrent Renal... Stage IV Melano... Stage IV Renal ... Unspecified Adu... | bryostatin 1 temsirolimus | 18 Years - | National Cancer Institute (NCI) | |
| Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer | NCT00087022 | Kidney Cancer | girentuximab placebo | 18 Years - 120 Years | Heidelberg Pharma AG | |
| Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer | NCT00492440 | Kidney Cancer Melanoma (Skin) | recombinant int... gene expression... polymerase chai... protein express... flow cytometry immunoenzyme te... immunologic tec... laboratory biom... pharmacological... | 18 Years - | Cytheris SA | |
| Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma | NCT00004244 | Kidney Cancer Melanoma (Skin) | recombinant int... recombinant int... | 18 Years - | National Cancer Institute (NCI) | |
| Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer | NCT00003102 | Kidney Cancer | Iodine-131 radi... | 16 Years - | Ludwig Institute for Cancer Research | |
| Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer | NCT00087022 | Kidney Cancer | girentuximab placebo | 18 Years - 120 Years | Heidelberg Pharma AG | |
| TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors | NCT02650635 | Colorectal Aden... Metastatic Panc... Recurrent Breas... Recurrent Color... Recurrent Melan... Recurrent Non-S... Recurrent Pancr... Recurrent Renal... Solid Neoplasm Stage IV Breast... Stage IV Non-Sm... Stage IV Renal ... Stage IV Skin M... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr... | Cyclophosphamid... Laboratory Biom... Pegfilgrastim Pharmacological... TLR8 Agonist VT... | 18 Years - | Mayo Clinic | |
| Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate | NCT01582009 | Clear Cell Rena... Recurrent Renal... Stage III Renal... Stage IV Renal ... | panobinostat everolimus laboratory biom... pharmacological... liquid chromato... mass spectromet... enzyme-linked i... immunohistochem... | 18 Years - | Roswell Park Cancer Institute | |
| Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery | NCT00003604 | Kidney Cancer | aldesleukin | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer | NCT00003584 | Kidney Cancer | estramustine ph... prednisone vinorelbine tar... | - 120 Years | University of New Mexico | |
| Vaccine Therapy in Treating Patients With Kidney Cancer | NCT00096629 | Kidney Cancer | human prostate-... mouse prostate-... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| ZD 1839 in Treating Patients With Metastatic Kidney Cancer | NCT00012337 | Kidney Cancer | gefitinib | - | National Cancer Institute (NCI) | |
| Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer | NCT00053807 | Kidney Cancer | aldesleukin recombinant int... fluorouracil adjuvant therap... | - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma | NCT00003091 | Kidney Cancer Melanoma (Skin) | aldesleukin recombinant int... | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer | NCT00727532 | Hereditary Clea... Kidney Cancer | Sorafenib | 18 Years - 120 Years | Northwestern University | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain | NCT00550654 | Kidney Cancer Melanoma (Skin) Metastatic Canc... Ovarian Cancer Sarcoma Unspecified Adu... | questionnaire a... 3-dimensional c... hypofractionate... image-guided ra... tomotherapy | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| PS-341 in Treating Patients With Metastatic Kidney Cancer | NCT00025376 | Kidney Cancer | PS-341 Tumor Biopsy | 18 Years - | University of Chicago | |
| Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery | NCT01164228 | Kidney Cancer | Gemcitabine Sunitinib | 18 Years - | Eastern Cooperative Oncology Group | |
| High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2 | NCT00080977 | Kidney Cancer | aldesleukin | 18 Years - | National Cancer Institute (NCI) | |
| DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE | NCT00900536 | Kidney Cancer | mutation analys... polymorphism an... protein express... immunohistochem... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer | NCT00100906 | Kidney Cancer | IL-2 ATRA | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial | NCT00316901 | Kidney Cancer Melanoma (Skin) | computed tomogr... positron emissi... fludeoxyglucose... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Chemotherapy in Treating Patients With Metastatic Kidney Cancer | NCT00024388 | Kidney Cancer | DHA-paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
| ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney Cancer | NCT00014183 | Kidney Cancer | gefitinib | 18 Years - 120 Years | University of Maryland, Baltimore | |
| Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery | NCT00293501 | Kidney Cancer | tinzaparin sodi... | 18 Years - | National Cancer Institute (NCI) | |
| Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies | NCT01243359 | Clear Cell Rena... Recurrent Renal... Stage I Renal C... Stage II Renal ... Stage III Renal... Stage IV Renal ... Unspecified Adu... | sunitinib malat... bevacizumab pharmacological... laboratory biom... fluorine F 18 f... positron emissi... computed tomogr... | 18 Years - | National Cancer Institute (NCI) | |
| Talabostat in Treating Patients With Metastatic Kidney Cancer | NCT00489710 | Kidney Cancer | talabostat mesy... enzyme inhibito... flow cytometry laboratory biom... non-specific im... | 19 Years - 120 Years | University of Nebraska | |
| Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer | NCT01599832 | Clear Cell Rena... Recurrent Renal... Stage IV Renal ... | pazopanib hydro... laboratory biom... dynamic contras... pharmacogenomic... | 18 Years - | University of Chicago | |
| Vaccine Therapy in Treating Patients With Advanced Kidney Cancer | NCT00004880 | Kidney Cancer | dendritic cell ... conventional su... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer | NCT00416429 | Kidney Cancer | aldesleukin recombinant int... medroxyprogeste... | 18 Years - | Centre Leon Berard | |
| SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer | NCT00900042 | Kidney Cancer | DNA ploidy anal... DNA stability a... chromosomal tra... cytogenetic ana... flow cytometry laboratory biom... | - | SWOG Cancer Research Network | |
| Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer | NCT00253708 | Cancer | management of t... massage therapy pain therapy psychosocial as... quality-of-life... | 18 Years - 120 Years | Beth Israel Deaconess Medical Center | |
| Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer | NCT00492440 | Kidney Cancer Melanoma (Skin) | recombinant int... gene expression... polymerase chai... protein express... flow cytometry immunoenzyme te... immunologic tec... laboratory biom... pharmacological... | 18 Years - | Cytheris SA | |
| Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | NCT00089362 | Male Breast Can... Recurrent Adeno... Recurrent Basal... Recurrent Breas... Recurrent Colon... Recurrent Esthe... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Melan... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage III Adeno... Stage III Basal... Stage III Colon... Stage III Esthe... Stage III Gastr... Stage III Inver... Stage III Lymph... Stage III Lymph... Stage III Melan... Stage III Midli... Stage III Mucoe... Stage III Ovari... Stage III Renal... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IIIB Brea... Stage IIIC Brea... Stage IV Adenoi... Stage IV Basal ... Stage IV Breast... Stage IV Colon ... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Melano... Stage IV Midlin... Stage IV Mucoep... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Unspecified Adu... Untreated Metas... | alvespimycin hy... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT00004095 | Bladder Cancer Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Pancreatic Canc... | gemcitabine hyd... irinotecan hydr... | 18 Years - 120 Years | Northwestern University | |
| Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer | NCT00016939 | Kidney Cancer | alvocidib | - | National Cancer Institute (NCI) | |
| DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC | NCT00085436 | Kidney Cancer | Aldesleukin, autologous tumo... recombinant int... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer | NCT00003181 | Kidney Cancer | aldesleukin sargramostim vinblastine sul... | 18 Years - | National Cancer Institute (NCI) | |
| Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer | NCT00849186 | Kidney Cancer | sunitinib malat... neoadjuvant the... therapeutic con... | 18 Years - | Roswell Park Cancer Institute | |
| Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors | NCT03682289 | Clear Cell Rena... Locally Advance... Locally Advance... Metastatic Mali... Metastatic Rena... Metastatic Urot... Metastatic Panc... Stage III Pancr... Stage III Renal... Stage IV Pancre... Stage IV Renal ... Endometrial Can... Metastatic Cast... | Ceralasertib Olaparib Durvalumab | 18 Years - | University of California, San Francisco | |
| RPI.4610 in Treating Patients With Metastatic Kidney Cancer | NCT00021021 | Kidney Cancer | anti-FLT-1 ribo... | 18 Years - | National Cancer Institute (NCI) | |
| Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy | NCT00896467 | Anal Cancer Anxiety Disorde... Breast Cancer Depression Esophageal Canc... Gallbladder Can... Gastric Cancer Kidney Cancer Liver Cancer Lung Cancer Pancreatic Canc... Small Intestine... | questionnaire a... psychosocial as... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer | NCT00005038 | Kidney Cancer | aldesleukin histamine dihyd... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Chemotherapy in Treating Patients With Advanced Kidney Cancer | NCT00011973 | Kidney Cancer | fenretinide | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer | NCT00093405 | Kidney Cancer | tanespimycin | 18 Years - | National Cancer Institute (NCI) | |
| Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer | NCT00126594 | Clear Cell Rena... Recurrent Renal... Stage IV Renal ... | Sorafenib Tosyl... Recombinant Int... Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung | NCT00006483 | Kidney Cancer Metastatic Canc... | sargramostim | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer | NCT00401128 | Kidney Cancer | gemcitabine hyd... irinotecan hydr... | 18 Years - 120 Years | The Cleveland Clinic | |
| Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer | NCT00053820 | Kidney Cancer | aldesleukin recombinant int... fluorouracil | 18 Years - 81 Years | National Cancer Institute (NCI) | |
| Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites | NCT04267575 | Recurrent Malig... Stage IV Breast... Stage IV Prosta... Stage IV Pancre... Stage IV Non-sm... Stage IV Ovaria... Stage IV Fallop... Stage IV Colon ... Stage IV Colore... Stage IV Liver ... Stage IV Renal ... Stage IV Rectal... Stage IV Lung C... Stage IV Small ... Stage IV Gastri... Stage IV Bladde... | Canady Helios C... | 18 Years - | Jerome Canady Research Institute for Advanced Biological & Technological Sciences | |
| Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer | NCT00016939 | Kidney Cancer | alvocidib | - | National Cancer Institute (NCI) | |
| Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery | NCT01688973 | Recurrent Renal... Stage III Renal... Stage IV Renal ... Type 1 Papillar... Type 2 Papillar... | Erlotinib Hydro... Laboratory Biom... Tivantinib | - | National Cancer Institute (NCI) | |
| Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma | NCT00617799 | Kidney Cancer Melanoma (Skin) | aldesleukin gene expression... mutation analys... flow cytometry | 19 Years - 120 Years | University of Nebraska | |
| Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer | NCT00003585 | Kidney Cancer | aldesleukin recombinant int... fluorouracil isotretinoin surgical proced... | - | University of New Mexico | |
| Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT00004095 | Bladder Cancer Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Pancreatic Canc... | gemcitabine hyd... irinotecan hydr... | 18 Years - 120 Years | Northwestern University | |
| Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer | NCT00003928 | Kidney Cancer | cisplatin gemcitabine hyd... | 18 Years - | Case Comprehensive Cancer Center | |
| Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer | NCT03260504 | Advanced Clear ... Stage III Renal... Stage IV Renal ... Metastatic Clea... | Aldesleukin Pembrolizumab | 18 Years - | University of Washington | |
| Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer | NCT00005045 | Kidney Cancer | carboxyamidotri... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
